Genetron Holdings Limited
NASDAQ: GTH0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Sizhen Wang
- Employees
- 993
- Headquarters
- Beijing, China
- IPO year
- 2020
- Market cap
- $127.3M
- Website
- https://www.genetronhealth.com
Loading GTH…
Loading profile data…Frequently asked questions about GTH
What does Genetron Holdings Limited (GTH) do?
Genetron Holdings Limited (GTH) is a precision oncology company that specializes in cancer molecular profiling, utilizing advanced molecular biology and data science to enhance cancer treatment. The company delivers a range of services, including diagnosis, monitoring, and early screening, primarily through its proprietary laboratory-developed t...
Where does GTH trade?
Genetron Holdings Limited (GTH) trades on the NASDAQ Global Market.
What sector is GTH in?
Genetron Holdings Limited (GTH) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Genetron Holdings Limited?
Sizhen Wang is the chief executive officer of Genetron Holdings Limited (GTH).
Where is Genetron Holdings Limited headquartered?
Genetron Holdings Limited is headquartered in China.
Does GTH pay a dividend?
Genetron Holdings Limited (GTH) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did GTH go public?
Genetron Holdings Limited (GTH) completed its initial public offering in 2020.
Is GTH an ADR?
Yes — GTH is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Genetron Holdings Limited reporting and dividends follow the underlying issuer.